Contact B'nai B'rith

1120 20th Street NW, Suite 300N Washington, D.C. 20036


Yaky Yanay, CEO of pioneering Israeli biotechnology company Pluri, speaks with B’nai B’rith CEO Dan Mariaschin about the range of next-generation cell-based products Pluri is creating to improve human wellbeing, increase sustainability, and advance solutions to humanity’s greatest challenges.

The Haifa-based company has its roots in regenerative medicine and plans to use its technology to continue driving cutting-edge medical research, and to create novel cell-based solutions for innovative initiatives in rapidly evolving sectors, including food tech, agri-tech and biologics.